Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo M Croce

Showing results (521-530 of 549) with videos related to

Pageof 55
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Plos Genetics|March 19, 2013
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor statusGianpiero Di Leva, Claudia Piovan, Pierluigi Gasparini, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaShih-Shih Chen, Aparna Raval, Amy J Johnson, et al.
ACS Chemical Biology|July 5, 2012
Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activityFrancesco Paduano, Francesco Ortuso, Pietro Campiglia, et al.
The New England Journal of Medicine|October 28, 2005
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemiaGeorge Adrian Calin, Manuela Ferracin, Amelia Cimmino, et al.
Oncogene|August 5, 2018
RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patientsAnna Tessari, Kareesma Parbhoo, Meghan Pawlikowski, et al.
Plos One|June 10, 2010
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivoDavid M Lucas, Lapo Alinari, Derek A West, et al.
Nature Communications|December 4, 2018
miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLCYoung-Jun Jeon, Taewan Kim, Dongju Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
tsRNA signatures in cancerVeronica Balatti, Giovanni Nigita, Dario Veneziano, et al.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Pageof 55

Showing results (521-530 of 549) with videos related to

Sort By:
Pageof 55
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Plos Genetics|March 19, 2013
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor statusGianpiero Di Leva, Claudia Piovan, Pierluigi Gasparini, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaShih-Shih Chen, Aparna Raval, Amy J Johnson, et al.
ACS Chemical Biology|July 5, 2012
Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activityFrancesco Paduano, Francesco Ortuso, Pietro Campiglia, et al.
The New England Journal of Medicine|October 28, 2005
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemiaGeorge Adrian Calin, Manuela Ferracin, Amelia Cimmino, et al.
Oncogene|August 5, 2018
RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patientsAnna Tessari, Kareesma Parbhoo, Meghan Pawlikowski, et al.
Plos One|June 10, 2010
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivoDavid M Lucas, Lapo Alinari, Derek A West, et al.
Nature Communications|December 4, 2018
miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLCYoung-Jun Jeon, Taewan Kim, Dongju Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
tsRNA signatures in cancerVeronica Balatti, Giovanni Nigita, Dario Veneziano, et al.
Nature Reviews. Cancer|May 31, 2020
Tumour predisposition and cancer syndromes as models to study gene-environment interactionsMichele Carbone, Sarah T Arron, Bruce Beutler, et al.
Pageof 55